Procurement of Consulting Services for the Research Study entitled “Process Evaluation and Implementation Review of Executive Order (EO) No. 104 s.2020 and EO NO. 155 s.2021” Click here for the complete information.
The Department of Health-Pharmaceutical Division (DOH-PD) in collaboration with the Philippine Pharmacists Association (PPhA) conducted a face-to-face Immunizing Pharmacist Certification Program (IPCP) for Public Health Pharmacists (PHPs) with a theme of, “Empowering Public Health Pharmacists as Frontliner in the midst of pandemic through the delivery of quality health care system for the integration of Universal Health Care.”
To read the full article, kindly click the title.
The Department of Health (DOH), together with other member agencies of the Inter-Agency Committee on Antimicrobial Resistance (ICAMR), culminated the week-long celebration of the Philippine Antimicrobial Awareness Week (PAAW) highlighting the importance of the One Health approach to combat antimicrobial resistance (AMR) fuelled by the COVID-19 pandemic threat.
Traversing towards the realization of quality primary healthcare through free access to essential medicines in support to the goals of the Universal Health Care in Region 1, Laoag City hosted the 17th Policy Dialogue on Universal Health Care and Access to Medicines through a Patient Forum at Sola Hotel, Laoag City, 18 November 2022.
OIC-SOH Singh-Vergeire Leads Launching of National Roadmap to Bolster Local Generics Industry
After three long years and five virtual policy dialogues, the Department of Health (DOH), its partner agencies and offices and the patient support groups and civil society organizations finally convened again face to face during the 16th Policy Dialogue on Universal Healthcare and Access to Medicines held on June 9, 2022 at Cocoon Boutique Hotel, Quezon City.
The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic.
The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.
The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.
The Department of Health (DOH) on March 30, 2022 convened patient groups and civil society organizations (CSOs) to discuss updates on the national government’s COVID-19 response, vaccination program rollout, and the ongoing initiatives to provide Filipinos better access to pharmaceutical commodities and healthcare services during the virtual 15th Policy Dialogue on Universal Health Care (UHC) and Access to Medicines with theme “Gamot Para sa Lahat, Siguruhing Sasapat”.